134 related articles for article (PubMed ID: 32481814)
61. Functionalized mesoporous silica nanoparticles and biomedical applications.
Hoang Thi TT; Cao VD; Nguyen TNQ; Hoang DT; Ngo VC; Nguyen DH
Mater Sci Eng C Mater Biol Appl; 2019 Jun; 99():631-656. PubMed ID: 30889738
[TBL] [Abstract][Full Text] [Related]
62. pH-Sensitive mesoporous silica nanoparticles anticancer prodrugs for sustained release of ursolic acid and the enhanced anti-cancer efficacy for hepatocellular carcinoma cancer.
Li T; Chen X; Liu Y; Fan L; Lin L; Xu Y; Chen S; Shao J
Eur J Pharm Sci; 2017 Jan; 96():456-463. PubMed ID: 27771513
[TBL] [Abstract][Full Text] [Related]
63. Multifunctional Redox-Responsive Mesoporous Silica Nanoparticles for Efficient Targeting Drug Delivery and Magnetic Resonance Imaging.
Chen L; Zhou X; Nie W; Zhang Q; Wang W; Zhang Y; He C
ACS Appl Mater Interfaces; 2016 Dec; 8(49):33829-33841. PubMed ID: 27960384
[TBL] [Abstract][Full Text] [Related]
64. pH-Responsive Release of Ruthenium Metallotherapeutics from Mesoporous Silica-Based Nanocarriers.
Mladenović M; Morgan I; Ilić N; Saoud M; Pergal MV; Kaluđerović GN; Knežević NŽ
Pharmaceutics; 2021 Mar; 13(4):. PubMed ID: 33800647
[TBL] [Abstract][Full Text] [Related]
65. pH-responsive nanoreservoirs based on hyaluronic acid end-capped mesoporous silica nanoparticles for targeted drug delivery.
Chen C; Sun W; Wang X; Wang Y; Wang P
Int J Biol Macromol; 2018 May; 111():1106-1115. PubMed ID: 29357289
[TBL] [Abstract][Full Text] [Related]
66. Transferrin gated mesoporous silica nanoparticles for redox-responsive and targeted drug delivery.
Chen X; Sun H; Hu J; Han X; Liu H; Hu Y
Colloids Surf B Biointerfaces; 2017 Apr; 152():77-84. PubMed ID: 28088015
[TBL] [Abstract][Full Text] [Related]
67. MUC1 aptamer-conjugated mesoporous silica nanoparticles effectively target breast cancer cells.
Hanafi-Bojd MY; Moosavian Kalat SA; Taghdisi SM; Ansari L; Abnous K; Malaekeh-Nikouei B
Drug Dev Ind Pharm; 2018 Jan; 44(1):13-18. PubMed ID: 28832225
[TBL] [Abstract][Full Text] [Related]
68. Polydopamine-based surface modification of mesoporous silica nanoparticles as pH-sensitive drug delivery vehicles for cancer therapy.
Chang D; Gao Y; Wang L; Liu G; Chen Y; Wang T; Tao W; Mei L; Huang L; Zeng X
J Colloid Interface Sci; 2016 Feb; 463():279-87. PubMed ID: 26550786
[TBL] [Abstract][Full Text] [Related]
69. Redox-responsive nanocarriers for drug and gene co-delivery based on chitosan derivatives modified mesoporous silica nanoparticles.
Lin JT; Liu ZK; Zhu QL; Rong XH; Liang CL; Wang J; Ma D; Sun J; Wang GH
Colloids Surf B Biointerfaces; 2017 Jul; 155():41-50. PubMed ID: 28407530
[TBL] [Abstract][Full Text] [Related]
70. Preparation and identification of multifunctional mesoporous silica nanoparticles for in vitro and in vivo dual-mode imaging, theranostics, and targeted tracking.
Chan MH; Lin HM
Biomaterials; 2015 Apr; 46():149-58. PubMed ID: 25678124
[TBL] [Abstract][Full Text] [Related]
71. Polymeric mesoporous silica nanoparticles as a pH-responsive switch to control doxorubicin intracellular delivery.
Tian Y; Glogowska A; Zhong W; Klonisch T; Xing M
J Mater Chem B; 2013 Oct; 1(39):5264-5272. PubMed ID: 32263329
[TBL] [Abstract][Full Text] [Related]
72. A focal adhesion kinase inhibitor 16-hydroxy-cleroda-3,13-dien-16,15-olide incorporated into enteric-coated nanoparticles for controlled anti-glioma drug delivery.
Thiyagarajan V; Lin SX; Lee CH; Weng CF
Colloids Surf B Biointerfaces; 2016 May; 141():120-131. PubMed ID: 26851441
[TBL] [Abstract][Full Text] [Related]
73. Cu
Zhang Y; Lou J; Williams GR; Ye Y; Ren D; Shi A; Wu J; Chen W; Zhu LM
Pharmaceutics; 2022 Jun; 14(6):. PubMed ID: 35745773
[TBL] [Abstract][Full Text] [Related]
74. Fluorescent carbon dot modified mesoporous silica nanocarriers for redox-responsive controlled drug delivery and bioimaging.
Jiao J; Liu C; Li X; Liu J; Di D; Zhang Y; Zhao Q; Wang S
J Colloid Interface Sci; 2016 Dec; 483():343-352. PubMed ID: 27569517
[TBL] [Abstract][Full Text] [Related]
75. Multifunctional mesoporous silica nanoparticles modified with tumor-shedable hyaluronic acid as carriers for doxorubicin.
Zhang J; Sun Y; Tian B; Li K; Wang L; Liang Y; Han J
Colloids Surf B Biointerfaces; 2016 Aug; 144():293-302. PubMed ID: 27107383
[TBL] [Abstract][Full Text] [Related]
76. Kinetics and Mechanism of Camptothecin Release from Transferrin-Gated Mesoporous Silica Nanoparticles through a pH-Responsive Surface Linker.
Jackson N; Ortiz AC; Jerez A; Morales J; Arriagada F
Pharmaceutics; 2023 May; 15(6):. PubMed ID: 37376039
[TBL] [Abstract][Full Text] [Related]
77. Curcumin-loaded guanidine functionalized PEGylated I3ad mesoporous silica nanoparticles KIT-6: practical strategy for the breast cancer therapy.
Ma'mani L; Nikzad S; Kheiri-Manjili H; Al-Musawi S; Saeedi M; Askarlou S; Foroumadi A; Shafiee A
Eur J Med Chem; 2014 Aug; 83():646-54. PubMed ID: 25014638
[TBL] [Abstract][Full Text] [Related]
78. Magnetic mesoporous silica nanoparticles end-capped with hydroxyapatite for pH-responsive drug release.
Zhao CX; Yu L; Middelberg APJ
J Mater Chem B; 2013 Oct; 1(37):4828-4833. PubMed ID: 32261164
[TBL] [Abstract][Full Text] [Related]
79. Mussel-inspired polydopamine coated mesoporous silica nanoparticles as pH-sensitive nanocarriers for controlled release.
Zheng Q; Lin T; Wu H; Guo L; Ye P; Hao Y; Guo Q; Jiang J; Fu F; Chen G
Int J Pharm; 2014 Mar; 463(1):22-6. PubMed ID: 24393764
[TBL] [Abstract][Full Text] [Related]
80. Effect of pH-responsive alginate/chitosan multilayers coating on delivery efficiency, cellular uptake and biodistribution of mesoporous silica nanoparticles based nanocarriers.
Feng W; Nie W; He C; Zhou X; Chen L; Qiu K; Wang W; Yin Z
ACS Appl Mater Interfaces; 2014 Jun; 6(11):8447-60. PubMed ID: 24745551
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
